Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity.
Ghosh A; Dogan Y; Moroz M; Holland AM; Yim NL; Rao UK; Young LF; Tannenbaum D; Masih D; Velardi E; Tsai JJ; Jenq RR; Penack O; Hanash AM; Smith OM; Piersanti K; Lezcano C; Murphy GF; Liu C; Palomba ML; Sauer MG; Sadelain M; Ponomarev V; van den Brink MR; The Journal Of Clinical Investigation, 2013, vol. 123, issue 6, p 2654, ISSN 15588238. ISBN 15588238.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef